Your browser doesn't support javascript.
Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium.
Bhaskar, Sonu; Bradley, Sian; Israeli-Korn, Simon; Menon, Bindu; Chattu, Vijay Kumar; Thomas, Pravin; Chawla, Jasvinder; Kumar, Rajeev; Prandi, Paolo; Ray, Daniel; Golla, Sailaja; Surya, Nirmal; Yang, Harvey; Martinez, Sandra; Ozgen, Mihriban Heval; Codrington, John; González, Eva María Jiménez; Toosi, Mandana; Hariya Mohan, Nithya; Menon, Koravangattu Valsraj; Chahidi, Abderrahmane; Mederer Hengstl, Susana.
  • Bhaskar S; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • Bradley S; Department of Neurology and Neurophysiology, Liverpool Hospital, Sydney, NSW, Australia.
  • Israeli-Korn S; Neurovascular Imaging Laboratory & NSW Brain Clot Bank, Ingham Institute for Applied Medical Research and South West Sydney Clinical School, The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia.
  • Menon B; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • Chattu VK; The University of New South Wales, UNSW Medicine, Sydney, NSW, Australia.
  • Thomas P; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • Chawla J; Department of Neurology, Sheba Medical Center, Tel Hashomer, Ramat Gan and Sackler School of Medicine, Movement Disorders Institute, Tel Aviv University, Tel Aviv-Yafo, Israel.
  • Kumar R; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • Prandi P; Department of Neurology, Apollo Hospitals, Nellore, India.
  • Ray D; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • Golla S; Department of Medicine, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Surya N; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • Yang H; Department of Neurology, University Hospitals NHS Foundation Trust, Birmingham, United Kingdom.
  • Martinez S; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • Ozgen MH; Department of Neurology, Loyola University Medical Center & Hines VA Hospital, Chicago, IL, United States.
  • Codrington J; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • González EMJ; Department of Psychiatry, Hamad Medical Center, Qatar & Australian National University, Canberra, ACT, Australia.
  • Toosi M; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • Hariya Mohan N; Department of Neurology, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy.
  • Menon KV; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
  • Chahidi A; Farr Institute of Health Informatics, University College London (UCL) & NHS Foundation Trust, Birmingham, United Kingdom.
  • Mederer Hengstl S; Pandemic Health System REsilience PROGRAM (REPROGRAM) Consortium, Chronic Neurology REPROGRAM Sub-committee†.
Front Neurol ; 11: 664, 2020.
Article in English | MEDLINE | ID: covidwho-658453
Semantic information from SemMedBD (by NLM)
1. Chronic disease PROCESS_OF Patients
Subject
Chronic disease
Predicate
PROCESS_OF
Object
Patients
2. Chronic disease PROCESS_OF Patients
Subject
Chronic disease
Predicate
PROCESS_OF
Object
Patients
ABSTRACT
With the rapid pace and scale of the emerging coronavirus 2019 (COVID-19) pandemic, a growing body of evidence has shown a strong association of COVID-19 with pre- and post- neurological complications. This has necessitated the need to incorporate targeted neurological care for this subgroup of patients which warrants further reorganization of services, healthcare workforce, and ongoing management of chronic neurological cases. The social distancing and the shutdown imposed by several nations in the midst of COVID-19 have severely impacted the ongoing care, access and support of patients with chronic neurological conditions such as Multiple Sclerosis, Epilepsy, Neuromuscular Disorders, Migraine, Dementia, and Parkinson disease. There is a pressing need for governing bodies including national and international professional associations, health ministries and health institutions to harmonize policies, guidelines, and recommendations relating to the management of chronic neurological conditions. These harmonized guidelines should ensure patient continuity across the spectrum of hospital and community care including the well-being, safety, and mental health of the patients, their care partners and the health professionals involved. This article provides an in-depth analysis of the impact of COVID-19 on chronic neurological conditions and specific recommendations to minimize the potential harm to those at high risk.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal: Front Neurol Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Prognostic study Language: English Journal: Front Neurol Year: 2020 Document Type: Article